Sn-protoporphyrin: a consideration of the first clinical trial in human neonates.
Stevenson
D K
DK
Department of Pediatrics, Stanford University School of Medicine, CA.
Vreman
H J
HJ
D002248:Carbon Monoxide / Q000378:metabolism; D002986:Clinical Trials as Topic; D006419:Heme Oxygenase (Decyclizing) / Q000037:antagonists & inhibitors; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000188:drug therapy*; D008665:Metalloporphyrins; D010787:Photosensitivity Disorders / Q000139:chemically induced; D011166:Porphyrins / Q000627:therapeutic use*; D011524:Protoporphyrins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D008665:Metalloporphyrins; D011166:Porphyrins; D011524:Protoporphyrins; D002248:Carbon Monoxide; C032628:tin protoporphyrin IX; D006419:Heme Oxygenase (Decyclizing)